Volunteer For UK Clinical Trials

Join our clinical trials to help shape the future of healthcare.

Participate in groundbreaking research and access new treatments. Your involvement supports medical advancements while you benefit from expert care.

Call us to join a clinical trial

"*" indicates required fields

Step 1 of 3

Submit your interest to our team of specialists

This field is hidden when viewing the form

Lead Source

First Name*

Last Name*

Email*

Phone Number*

Explore the page

About Our Clinical Trials
Benefits
Types of Trials Available
What to Expect
Clinic Locations

About Our Clinical Trials

Clinical trials help researchers test new treatments and improve healthcare for people with dementia and cognitive impairment. These studies are essential for finding better ways to prevent, diagnose, and treat medical conditions.

In 2023/24, over a million people in the UK took part in health and social care research, according to the National Institute for Health and Care Research (NIHR). Every study brings us closer to new treatments – and possibly even a cure.

By joining a clinical trial, you can play a vital role in shaping the future of medicine.

Benefits Of Joining A Clinical Trial

Participation is completely free and voluntary, with no costs or obligations
Help develop new treatments that could benefit future generations
Gain early access to potential new treatments for memory loss with close medical monitoring
Receive expert medical care at no cost, including comprehensive health checks, MRI scans, and PET scans
Your GP will be kept informed throughout the study
Avoid long NHS waiting lists and access specialist private healthcare
Travel expenses are reimbursed for each visit
Complimentary refreshments are provided

Types of Clinical Trials Available

According to the Alzheimer’s Society, over 1 million people in the UK will have a diagnosis of dementia by 2025. By 2051 this number will exceed 2 million. Worldwide it’s estimated that 82 million people will be suffering from dementia by 2030.

We are currently looking for volunteers to participate in these studies.

Learn More
Mild Cognitive Impairment affects between 5-20% of people aged 65 years and over in the UK. It is not a form of dementia, however, individuals with MCI often progress to developing dementia.

We are currently looking for volunteers to participate in these studies.

Learn More
Much research is underway in the field of Parkinson’s disease to determine why people develop this condition, as well as new treatments to help treat its symptoms. It is thought that Parkinson’s is caused by a combination of genetic and environmental factors.

We are currently looking for volunteers to participate in these studies.

Learn More
At present, there is no cure for Migraine. We’re working on a range of treatment options to change that. Migraines are unbelievably common in the UK, affecting up to 12 million people.

We are currently looking for volunteers to participate in these studies.

Learn More
We recognise that neurodiversity provides fantastic benefits, as evidenced by the numerous attributes and skills exhibited by individuals living very successful lives with autism.

We are currently looking for volunteers to participate in these studies.

Learn More
The currently approved disease-modifying therapies aren’t a cure for MS, but they can reduce how many relapses someone has and how serious they are. They can also slow down the damage caused by relapsing multiple sclerosis that builds up over time. The studies we conduct at Re:Cognition Health are also disease-modifying therapies however aiming to improve the efficacy (the success in slowing progression and/or symptoms) of current medications used.

We are currently looking for volunteers to participate in these studies.

Learn More
ADHD/ADD is not an illness, but a condition. This means it may predispose individuals to suffer medical and psychiatric conditions like depression, anxiety, conduct disorder, and alcohol and substance abuse. However, a diagnosis of ADHD doesn’t necessarily mean that individuals will have negative outcomes later in life.

Learn More

1

Step 1

Quick pre-screening call with our patient engagement team to check which studies are suitable.
2

Step 2

Onsite screening consultation with our experienced doctors.
3

Step 3

If eligible, you will gain access to new medications or interventions, that have the potential to change lives.

Our Clinics

Clinic Locations

Our clinics located throughout the UK are set up for your comfort with experts and consultants to walk you through the clinical trial process.

We have clinics in London, Guildford, Plymouth, Birmingham, Winchester and Bristol.

Access Cutting-Edge Clinical Trials Through Our PPD Select Partnership Programme

We’re thrilled to be a preferred site within the PPD Select Partnership Programme, a key initiative of Thermo Fisher Scientific’s PPD clinical research business, a global leader in clinical research.

This partnership opens up exciting opportunities for our patients and participants. By working with PPD’s Strategic Site Collaborations team, we’re able to offer access to cutting-edge clinical trials and provide the highest quality of care across our ten locations in the UK and USA.

We’re committed to continuously enhancing our services and providing you with the best research opportunities available.

Alzheimer's: A Turning Point?

Re:Cognition Health has recently been featured on BBC One’s Panorama, “Alzheimer’s: A Turning Point?”. This follows the journey of volunteers participating in clinical trials, some from Re:Cognition Health’s UK centres, testing new-generation medications designed to slow down the progression of the disease. For those in the UK, you can still watch this on BBC iPlayer.

Watch on BBC iPlayer

Clinical Trials And New Medications For Alzheimer's

Dr Emer MacSweeney, CEO and Founder of Re:Cognition Health, discusses the latest medications available for Alzheimer’s disease. In this video, we hear from clinical trial participants Mike and David, as well as trial partner Cheryl, who share how participating in clinical trials for these new treatments has positively impacted their lives.